ACIN1
Basic information
Region (hg38): 14:23058564-23095614
Previous symbols: [ "ACINUS" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACIN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 72 | 72 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 72 | 2 | 0 |
Variants in ACIN1
This is a list of pathogenic ClinVar variants found in the ACIN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-23059212-G-A | not specified | Uncertain significance (Jan 19, 2022) | ||
14-23059291-T-C | not specified | Uncertain significance (Oct 13, 2021) | ||
14-23061333-C-A | not specified | Uncertain significance (May 30, 2024) | ||
14-23061348-C-T | not specified | Uncertain significance (May 28, 2024) | ||
14-23061366-C-T | not specified | Uncertain significance (May 17, 2023) | ||
14-23061384-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
14-23061397-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
14-23061457-C-T | not specified | Uncertain significance (Jan 17, 2024) | ||
14-23061501-C-T | not specified | Uncertain significance (Jun 11, 2024) | ||
14-23061502-G-A | not specified | Uncertain significance (Mar 21, 2023) | ||
14-23061566-C-A | not specified | Uncertain significance (Mar 29, 2023) | ||
14-23061606-C-T | not specified | Uncertain significance (Aug 14, 2023) | ||
14-23062230-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
14-23062417-G-A | not specified | Uncertain significance (Dec 06, 2021) | ||
14-23062466-C-T | not specified | Uncertain significance (May 25, 2022) | ||
14-23062484-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
14-23063024-C-T | not specified | Uncertain significance (Sep 13, 2023) | ||
14-23063053-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
14-23064188-G-A | not specified | Uncertain significance (May 31, 2023) | ||
14-23064229-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
14-23065972-C-T | not specified | Uncertain significance (May 22, 2023) | ||
14-23066004-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
14-23066007-C-T | not specified | Uncertain significance (May 09, 2023) | ||
14-23069513-C-T | not specified | Uncertain significance (May 27, 2022) | ||
14-23069514-G-A | not specified | Uncertain significance (Dec 08, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACIN1 | protein_coding | protein_coding | ENST00000262710 | 19 | 37051 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000194 | 125707 | 0 | 41 | 125748 | 0.000163 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.20 | 601 | 773 | 0.777 | 0.0000478 | 8583 |
Missense in Polyphen | 180 | 272.83 | 0.65975 | 2948 | ||
Synonymous | -1.31 | 306 | 278 | 1.10 | 0.0000141 | 2746 |
Loss of Function | 6.99 | 8 | 72.0 | 0.111 | 0.00000466 | 801 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000904 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000212 | 0.000211 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000198 | 0.000196 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Auxiliary component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. Component of the ASAP complexes which bind RNA in a sequence- independent manner and are proposed to be recruited to the EJC prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets; ACIN1 confers RNA-binding to the complex. The ASAP complex can inhibit RNA processing during in vitro splicing reactions. The ASAP complex promotes apoptosis and is disassembled after induction of apoptosis. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits formation of proapoptotic isoforms such as Bcl-X(S); the activity is different from the established EJC assembly and function. Induces apoptotic chromatin condensation after activation by CASP3. Regulates cyclin A1, but not cyclin A2, expression in leukemia cells. {ECO:0000269|PubMed:10490026, ECO:0000269|PubMed:12665594, ECO:0000269|PubMed:18559500, ECO:0000269|PubMed:22203037, ECO:0000269|PubMed:22388736}.;
- Pathway
- mRNA surveillance pathway - Homo sapiens (human);RNA transport - Homo sapiens (human);Spliceosome - Homo sapiens (human);Apoptotic cleavage of cellular proteins;Apoptotic execution phase;Apoptosis;Programmed Cell Death
(Consensus)
Recessive Scores
- pRec
- 0.423
Intolerance Scores
- loftool
- 0.464
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.71
Haploinsufficiency Scores
- pHI
- 0.757
- hipred
- Y
- hipred_score
- 0.655
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.948
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Acin1
- Phenotype
Gene ontology
- Biological process
- mRNA processing;RNA splicing;erythrocyte differentiation;apoptotic chromosome condensation;positive regulation of monocyte differentiation
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytosol;plasma membrane;nuclear speck;ASAP complex
- Molecular function
- nucleic acid binding;RNA binding;protein binding;ATPase activity;enzyme binding